Essential Site Maintenance: Authorea-powered sites will be updated circa 15:00-17:00 Eastern on Tuesday 5 November.
There should be no interruption to normal services, but please contact us at [email protected] in case you face any issues.

loading page

Safety and Efficacy of Cryoballoon versus Radiofrequency Ablation for Atrial Fibrillation in Elderly Patients and Predictors of Arrhythmia Recurrence
  • +6
  • Tauseef Akhtar,
  • Usama Daimee,
  • Bhradeev Sivasambu,
  • Erica Hart,
  • Eunice Yang,
  • Joseph Marine,
  • Ronald Berger,
  • Hugh Calkins,
  • David Spragg
Tauseef Akhtar
Johns Hopkins School of Medicine

Corresponding Author:[email protected]

Author Profile
Usama Daimee
Johns Hopkins University School of Medicine
Author Profile
Bhradeev Sivasambu
Johns Hopkins Medicine
Author Profile
Erica Hart
Johns Hopkins University School of Medicine
Author Profile
Eunice Yang
Johns Hopkins Hospital
Author Profile
Joseph Marine
Johns Hopkins Hospital
Author Profile
Ronald Berger
Johns Hopkins Hospital
Author Profile
Hugh Calkins
Johns Hopkins Hospital
Author Profile
David Spragg
Johns Hopkins Hospital
Author Profile

Abstract

Introduction: There are limited data describing the experience of index radiofrequency (RF) vs. cryoballoon (CB) ablation for atrial fibrillation (AF) among elderly patients in the United States. Methods: We conducted a retrospective analysis of patients > 75 years of age undergoing index AF ablation between January 2010 and March 2019 at our center. Major complications and efficacy, defined as freedom from any atrial tachyarrhythmia (ATA) lasting ≥30 seconds after one year of follow-up, were assessed in patients with index RF vs. CB ablation. Predictors of ATA recurrence at 1 year follow-up were also evaluated. Results: In our cohort of 194 patients, the mean age was 78 ± 3.1 years, 58.2% were men, and 39.4% had persistent AF. The mean left atrial (LA) diameter was 4.5 ± 0.7, while the mean CHA2DS2-VASc score was 3.5 ± 1.2. The majority (n=149, 76.8%) underwent RF ablation. The incidence of complications was similar in the two sub-groups (RF: 1.3% vs. CB: 2.2%, p=0.67). No significant difference in success rate at 1-year follow-up was found between patients receiving RF vs. CB ablation (59.7% vs. 66.7%, p=0.68). In a multivariable model adjusting for the relevant covariates only LA size [HR=1.64, CI: 1.15-2.34, p<0.01] was independently associated with ATA recurrence at 1year follow-up. Conclusion: In our cohort of elderly patients undergoing index CA for AF, RF ablation was the predominant modality with similar safety and efficacy relative to CB ablation. LA size was a significant predictor of ATA recurrence at 1year independent of index ablation modality.